STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Operating expenses
Research and development	$ 218,069	$ 207,651	$ 614,240	$ 545,960
General and administrative	214,946	44,988	358,284	154,334
Total operating expenses	433,015	252,639	972,524	700,294
Operating loss	(433,015)	(252,639)	(972,524)	(700,294)
Loss before provision for income tax	(433,015)	(252,639)	(972,524)	(700,294)
Provision for income tax	0	0	0	0
Net loss	$ (433,015)	$ (252,639)	$ (972,524)	$ (700,294)
Earnings per share information:
Loss per common share Basic	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
Loss per common share Diluted	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
Weighted average common shares outstanding:
Weighted average number of common shares outstanding Basic	131,448,444	131,448,444	131,448,444	131,448,444
Weighted average number of common shares outstanding Diluted	131,448,444	131,448,444	131,448,444	131,448,444